| Item Type | Name |
|
Academic Article
|
Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.
|
|
Concept
|
Interleukin-7 Receptor alpha Subunit
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Receptors, Interleukin-7
|
|
Concept
|
Interleukin 1 Receptor Antagonist Protein
|
|
Concept
|
Receptors, Interleukin-1
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Interleukin-4
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Receptors, Interleukin
|
|
Concept
|
Interleukin-11
|
|
Concept
|
Receptors, Interleukin-3
|
|
Concept
|
Interleukin-7
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Interleukin-3
|
|
Academic Article
|
Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
|
|
Academic Article
|
Growth factors controlling interleukin-4 action on hematopoietic progenitors.
|
|
Academic Article
|
B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
|
|
Academic Article
|
Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation.
|
|
Academic Article
|
Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.
|
|
Academic Article
|
Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia.
|
|
Academic Article
|
Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence.
|
|
Academic Article
|
Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.
|
|
Academic Article
|
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
|
|
Academic Article
|
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia.
|
|
Academic Article
|
Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.
|
|
Academic Article
|
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.
|
|
Academic Article
|
Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
|
|
Academic Article
|
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis.
|
|
Academic Article
|
Cytokines and their antagonists in myeloid disorders.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma.
|
|
Academic Article
|
Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates.
|
|
Academic Article
|
Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
|
|
Academic Article
|
Interleukin-1 and its inhibitors: a biologic and therapeutic model for the role of growth regulatory factors in leukemias.
|
|
Academic Article
|
Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.
|
|
Academic Article
|
Phase II study of low-dose interleukin-11 in patients with myelodysplastic syndrome.
|
|
Academic Article
|
The modulatory hematopoietic activities of leukemia inhibitory factor.
|
|
Academic Article
|
Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.
|
|
Academic Article
|
Cytokines in tumor therapy. Interleukin-3.
|
|
Academic Article
|
Diamond-Blackfan anemia: promotion of marrow erythropoiesis in vitro by recombinant interleukin-3.
|
|
Academic Article
|
The regulatory role of interleukin 2-responsive T lymphocytes on human marrow granulopoiesis.
|
|
Academic Article
|
Interleukin 4 alters human bone marrow stroma and modulates its interaction with hematopoietic progenitors.
|
|
Academic Article
|
Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
|
|
Academic Article
|
Interruption of autocrine and paracrine growth-stimulatory mechanisms: a new therapeutic strategy for chronic myelogenous leukemia.
|
|
Academic Article
|
Effect of interleukin-1 beta converting enzyme inhibitor on acute myelogenous leukemia progenitor proliferation.
|
|
Academic Article
|
Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell death.
|
|
Academic Article
|
Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
|
|
Academic Article
|
Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
|
|
Academic Article
|
Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
|
|
Academic Article
|
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
|
|
Academic Article
|
Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
|
|
Academic Article
|
The regulatory role of interleukin 2-responsive T lymphocytes on early and mature erythroid progenitor proliferation.
|
|
Academic Article
|
Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
|
|
Academic Article
|
Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
|
|
Academic Article
|
Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
|
|
Academic Article
|
1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.
|
|
Academic Article
|
Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines.
|
|
Academic Article
|
LIF: not just a leukemia inhibitory factor.
|
|
Academic Article
|
Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.
|
|
Academic Article
|
Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.
|
|
Academic Article
|
Interleukin-1 and its inhibitors: implications for disease biology and therapy.
|
|
Academic Article
|
Suppressed formation of bone marrow adherent layers derived from acute myeloid leukemia patients after in vitro exposure to interleukin-4.
|
|
Academic Article
|
Role of interleukin-1 beta converting enzyme (ICE) in leukemia.
|
|
Academic Article
|
Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
|
|
Academic Article
|
Interleukin-7 receptor-a gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
|
|
Academic Article
|
Activation of the B-cell receptor successively activates NF-?B and STAT3 in chronic lymphocytic leukemia cells.
|
|
Academic Article
|
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
|